Benzodiazépines et personnes âgées

Benzodiazepines and related molecules are widely prescribed in geriatrics, causing numerous somatic and cognitive complications. Despite incitement and repeated recommendations for a “reasoned” prescription of these substances, it is clear that these treatments are still prescribed for prolonged periods, raising many questions about possible links between prolonged exposure and onset of cognitive decline or even dementia and the risk of addiction. In a risk-reduction perspective, the prevention of iatrogenic complications arising from benzodiazepines or related molecules requires cautious prescription, and discontinuation, or at least dose reduction of these drugs should be encouraged whatever the age of the subject.